402
Participants
Start Date
September 30, 2010
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
DRONEDARONE
Pharmaceutical form: tablet Route of administration: oral Dose regimen: 400 mg
Investigational Site Number 158002, Taipei
Investigational Site Number 158004, Taichung
Investigational Site Number 158003, Taichung
Investigational Site Number 158006, Kaohsiung City
Investigational Site Number 040-005, Vienna
Investigational Site Number 010, Maroubra
Investigational Site Number 006, Liverpool
Investigational Site Number 004, New Lambton
Investigational Site Number 040-001, Mödling
Investigational Site Number 002, Garran
Investigational Site Number 013, Ballarat
Investigational Site Number 007, Herston
Investigational Site Number 040-002, Linz
Investigational Site Number 008, Redcliffe
Investigational Site Number 756001, Basel
Investigational Site Number 011, South Brisbane
Investigational Site Number 003, Woolloongabba
Investigational Site Number 005, Southport
Investigational Site Number 009, Adelaide
Investigational Site Number 040-006, Braunau am Inn
Investigational Site Number 001, Nedlands
Investigational Site Number 040-007, Innsbruck
Investigational Site Number 012, Hobart
Investigational Site Number 756002, Sankt Gallen
Investigational Site Number 233001, Tallinn
Investigational Site Number 276-003, Berlin
Investigational Site Number 724008, A Coruña
Investigational Site Number 276-006, Bernau
Investigational Site Number 484017, Aguascalientes
Investigational Site Number 380-012, Varese
Investigational Site Number 276-002, Hamburg
Investigational Site Number 380-001, Como
Investigational Site Number 484011, Tijuana
Investigational Site Number 276-008, Hamburg
Investigational Site Number 276-004, Kiel
Investigational Site Number 484013, Saltillo
Investigational Site Number 250-005, Valence
Investigational Site Number 724010, Madrid
Investigational Site Number 724001, Madrid
Investigational Site Number 246-004, Pori
Investigational Site Number 724002, Majadahonda
Investigational Site Number 250-010, Nîmes
Investigational Site Number 724004, El Palmar (murcia)
Investigational Site Number 380-011, Mestre
Investigational Site Number 250-004, Toulouse
Investigational Site Number 484012, Chihuahua City
Investigational Site Number 380-009, San Daniele del Friuli
Investigational Site Number 276-007, Paderborn
Investigational Site Number 250-009, Béziers
Investigational Site Number 484002, León
Investigational Site Number 724006, Seville
Investigational Site Number 724007, Tarragona
Investigational Site Number 484008, Guadalajara
Investigational Site Number 484009, Guadalajara
Investigational Site Number 484015, Guadalajara
Investigational Site Number 724009, Valencia
Investigational Site Number 250-007, Cholet
Investigational Site Number 380-006, Cortona
Investigational Site Number 276-001, Bonn
Investigational Site Number 250-001, Vandœuvre-lès-Nancy
Investigational Site Number 380-002, Barga
Investigational Site Number 380-005, Ancona
Investigational Site Number 246-003, Seinäjoki
Investigational Site Number 276-010, Frankfurt am Main
Investigational Site Number 484005, Monterrey
Investigational Site Number 484003, Monterrey
Investigational Site Number 250-008, Lyon
Investigational Site Number 250-002, Bron
Investigational Site Number 276-005, Ludwigsburg
Investigational Site Number 484001, Querétaro
Investigational Site Number 250-006, Avignon
Investigational Site Number 250-003, Poitiers
Investigational Site Number 380-010, Palermo
Investigational Site Number 380-004, Catania
Investigational Site Number 040-003, Vienna
Investigational Site Number 040-004, Vienna
Investigational Site Number 376002, Ashkelon
Investigational Site Number 376001, Beer Yaakov
Investigational Site Number 528003, Amsterdam
Investigational Site Number 528005, Goes
Investigational Site Number 528002, Groningen
Investigational Site Number 528001, Maastricht
Investigational Site Number 528004, Rotterdam
Investigational Site Number 410002, Seoul
Investigational Site Number 410003, Seoul
Investigational Site Number 410004, Seoul
Investigational Site Number 410005, Seoul
Investigational Site Number 724003, Lleida
Investigational Site Number 158005, Kaohsiung Hsien,
Investigational Site Number 158009, Taichung
Investigational Site Number 158001, Taipei
Investigational Site Number 158008, Taipei
Investigational Site Number 158007, Tao Yuan Hsien
Investigational Site Number 246-001, Hyvinkää
Investigational Site Number 246-002, Hyvinkää
Investigational Site Number 276-011, Dresden
Investigational Site Number 276-009, Heidenau
Investigational Site Number 380-007, Roma
Investigational Site Number 380-003, Roma
Investigational Site Number 484016, México
Investigational Site Number 484004, México
Investigational Site Number 620005, Amadora
Investigational Site Number 620001, Lisbon
Investigational Site Number 410001, Seoul
Investigational Site Number 410006, Suwon
Investigational Site Number 724005, L'Hospitalet de Llobregat
Investigational Site Number 826006, Belfast
Investigational Site Number 826-005, Bournemouth
Investigational Site Number 826-001, Carshalton
Investigational Site Number 826-002, Gloucester
Investigational Site Number 826-007, Wrexham
Lead Sponsor
Sanofi
INDUSTRY